Novartis: revenue up 4% in 3Q to $14.5 billion
To save an article you must be connected, so you can view them on all your devices.
Swiss pharmaceutical giant Novartis published better-than-expected third-quarter revenue on Tuesday, up 4% to $14.5 billion (€13 billion) and raised one of its financial targets.
Its net profit, on the other hand, fell by 70% to nearly $1.2 billion, weighed down by a partial depreciation of assets on del-desiran, a treatment being studied against a neuromuscular disease which suffered a setback in a study during clinical trials, he said in a press release.
Machine-translated from French
Not cross-checked yet
Only Le Figaro reports this story so far. We show it as a single source until another newsroom confirms it.
- Le Figaro27 Oct, 08:16Novartis: revenue up 4% in 3Q to $14.5 billion ↗Figures: 14.5 milliards
| Publisher Le Figaro (established tier) | +76 |
| Summary too short | -6 |
| Total | 70 |
Method: reports are grouped by the words of their headline and summary; each newsroom counts once; figures are read from the reports as published. Nothing here is written by an AI.